LT1644009T - Kompozicijos telomerazių aktyvumo didinimui ir živ infekcijos gydymui - Google Patents
Kompozicijos telomerazių aktyvumo didinimui ir živ infekcijos gydymuiInfo
- Publication number
- LT1644009T LT1644009T LTEP04777032.6T LT04777032T LT1644009T LT 1644009 T LT1644009 T LT 1644009T LT 04777032 T LT04777032 T LT 04777032T LT 1644009 T LT1644009 T LT 1644009T
- Authority
- LT
- Lithuania
- Prior art keywords
- compositions
- hiv infection
- telomerase activity
- treating hiv
- increasing telomerase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48098803P | 2003-06-23 | 2003-06-23 | |
PCT/US2004/020277 WO2005000245A2 (en) | 2003-06-23 | 2004-06-23 | Compositions and methods for increasing telomerase activity |
Publications (1)
Publication Number | Publication Date |
---|---|
LT1644009T true LT1644009T (lt) | 2018-03-12 |
Family
ID=33551962
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP12180710.1T LT2548880T (lt) | 2003-06-23 | 2004-06-23 | Kompozicijos telomerazės aktyvumui didinti |
LTEP04777032.6T LT1644009T (lt) | 2003-06-23 | 2004-06-23 | Kompozicijos telomerazių aktyvumo didinimui ir živ infekcijos gydymui |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP12180710.1T LT2548880T (lt) | 2003-06-23 | 2004-06-23 | Kompozicijos telomerazės aktyvumui didinti |
Country Status (24)
Country | Link |
---|---|
US (3) | US7846904B2 (lt) |
EP (2) | EP1644009B1 (lt) |
JP (4) | JP5583882B2 (lt) |
KR (3) | KR101312389B1 (lt) |
CN (1) | CN1809364B (lt) |
AP (1) | AP2280A (lt) |
AU (2) | AU2004251753C1 (lt) |
BR (1) | BRPI0411856A (lt) |
CA (1) | CA2528483C (lt) |
CY (2) | CY1119951T1 (lt) |
DK (2) | DK2548880T3 (lt) |
EA (1) | EA009442B1 (lt) |
ES (2) | ES2666864T3 (lt) |
HR (2) | HRP20180330T1 (lt) |
HU (2) | HUE043168T2 (lt) |
LT (2) | LT2548880T (lt) |
MX (1) | MXPA05013844A (lt) |
NZ (1) | NZ544191A (lt) |
PL (2) | PL2548880T3 (lt) |
PT (2) | PT1644009T (lt) |
SI (2) | SI2548880T1 (lt) |
TR (2) | TR201903587T4 (lt) |
WO (1) | WO2005000245A2 (lt) |
ZA (1) | ZA200509846B (lt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
US6337200B1 (en) | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
TR201903587T4 (tr) | 2003-06-23 | 2019-04-22 | Telomerase Activation Sciences Inc | Telomeraz aktivitesinin artırılması için bileşimler. |
WO2005000248A2 (en) * | 2003-06-25 | 2005-01-06 | Geron Corporation | Compositions and methods for skin conditioning |
US7998938B2 (en) | 2005-04-15 | 2011-08-16 | Geron Corporation | Cancer treatment by combined inhibition of proteasome and telomerase activities |
US8197860B2 (en) * | 2005-06-23 | 2012-06-12 | Nuliv Holding Inc. | Method for enhancing nutrient absorption with astragalosides |
CN100333731C (zh) * | 2005-09-08 | 2007-08-29 | 南京医科大学 | 黄芪甲苷在制备治疗糖尿病周围神经病变药物中的应用 |
CN100384830C (zh) * | 2006-01-12 | 2008-04-30 | 天津药物研究院 | 环黄芪醇类衍生物以及用途 |
US7992749B2 (en) | 2006-03-30 | 2011-08-09 | Nike, Inc. | Support element for a carry strap |
EP2101789B1 (en) | 2006-10-30 | 2014-12-31 | Geron Corporation | Combined telomerase inhibitor and gemcitabine for the treatment of cancer |
MX2009013354A (es) | 2007-06-04 | 2010-07-06 | Univ Ben Gurion | Compuestos de triarilo y composiciones que los contienen. |
CN101225424B (zh) * | 2007-09-13 | 2013-05-29 | 天津药物研究院 | 环黄芪醇的单葡萄糖苷、其制备方法、药物组合物和应用 |
US8168596B2 (en) * | 2008-10-17 | 2012-05-01 | Nuliv Holding Inc. | Use of cycloartane compounds for treating arthritis |
EP2437606B1 (en) * | 2009-05-18 | 2016-07-27 | Telomerase Activation Sciences, Inc. | Compositions and methods for increasing telomerase activity |
CA2912698A1 (en) * | 2013-05-15 | 2014-11-20 | Fybrands Corp. | Compositions for improving the hair, skin, and nails |
CA2928725A1 (en) | 2013-11-05 | 2015-05-14 | Esther Priel | Compounds for the treatment of diabetes and disease complications arising from same |
CN104435370A (zh) * | 2014-12-06 | 2015-03-25 | 王香平 | 风湿保健酒 |
CN104491185A (zh) * | 2014-12-06 | 2015-04-08 | 郭亮 | 一种祛风湿药酒及其制备方法 |
CN104435371A (zh) * | 2014-12-06 | 2015-03-25 | 郭亮 | 一种用于治疗关节炎的药酒 |
KR20160069857A (ko) | 2014-12-09 | 2016-06-17 | (주)스피어테크 | 텔로미어 활성을 증가시키기 위한 조성물 및 그 조성물의 제조방법 |
CN104817610A (zh) * | 2015-03-15 | 2015-08-05 | 北京化工大学 | 利用硫酸水解制备环黄芪醇的方法 |
US10100285B2 (en) | 2015-04-03 | 2018-10-16 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
CA2981708A1 (en) | 2015-04-03 | 2016-10-06 | Chengkang ZHANG | Ex vivo proliferation of epithelial cells |
CN106474094A (zh) * | 2015-08-31 | 2017-03-08 | 南京理工大学 | 一种环黄芪醇电纺纤维膜及其制备方法 |
EP3892717A1 (en) | 2015-09-11 | 2021-10-13 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
CN106307522A (zh) * | 2016-11-06 | 2017-01-11 | 谭淞文 | 一种抗衰老保健品及其制备方法和食用方法 |
CN106831927B (zh) * | 2017-02-07 | 2018-02-09 | 江西师范大学 | 一种黄芪甲苷的合成方法 |
CN108498521B (zh) * | 2017-02-24 | 2020-05-05 | 北京大学 | 环黄芪醇在制备抑制腹主动脉瘤的药物中的应用 |
US10098922B1 (en) | 2017-11-30 | 2018-10-16 | Optigenex, Inc. | Increasing telomere length in a cell |
CA3145888A1 (en) * | 2018-07-31 | 2020-02-06 | Isilay KAVADARLI | Ophthalmic formulations and uses thereof |
CN111053782A (zh) | 2018-10-17 | 2020-04-24 | 株式会社爱茉莉太平洋 | 包含新型人参皂苷的组合物 |
KR102635196B1 (ko) | 2018-10-17 | 2024-02-13 | (주)아모레퍼시픽 | 신규 진세노사이드를 포함하는 미백 조성물 |
US11000538B2 (en) | 2018-10-31 | 2021-05-11 | Amorepacific Corporation | Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside |
WO2020131058A1 (en) * | 2018-12-20 | 2020-06-25 | Muhammed Majeed | Telomerase enhancement potential of ecdysterone |
CN109942663B (zh) * | 2019-04-22 | 2021-10-26 | 中国人民解放军联勤保障部队第九八九医院 | 利用双相酸水解制备环黄芪醇的方法 |
MX2019006749A (es) | 2019-06-10 | 2022-11-28 | Univ Mexico Nac Autonoma | Compuestos activadores de senescencia celular. |
KR20210037256A (ko) | 2019-09-27 | 2021-04-06 | (주)아모레퍼시픽 | 신규 진세노사이드를 포함하는 갱년기 증상의 예방 또는 개선용 조성물 |
KR20210037257A (ko) | 2019-09-27 | 2021-04-06 | (주)아모레퍼시픽 | 신규 진세노사이드를 포함하는 피부 탄력 개선용 조성물 |
CN111419854B (zh) * | 2020-05-18 | 2021-03-30 | 南通大学 | 具有特殊七元环结构的三萜在制备预防和治疗神经损伤药物中的应用 |
CN113480628B (zh) * | 2021-08-17 | 2022-06-21 | 贵州师范大学 | 一种贵州疣螈多肽tk-cath及其编码基因和应用 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6212791A (ja) * | 1986-07-18 | 1987-01-21 | Osaka Chem Lab | オウギサポニン、その単離法およびその用途 |
JPS6212792A (ja) * | 1986-07-18 | 1987-01-21 | Osaka Chem Lab | オウギサポニン類の単離法 |
IT1259645B (it) | 1992-04-10 | 1996-03-25 | Solis Srl | Metodo per la rivelazione della variazione di densita' di un tessuto e dispositivo per la sua attuazione |
US6007989A (en) * | 1992-05-13 | 1999-12-28 | Board Of Regents, The University Of Texas System | Methods of screening for compounds that derepress or increase telomerase activity |
US5629154A (en) * | 1993-11-12 | 1997-05-13 | Geron Corporation | Telomerase activity assays |
FR2695561B1 (fr) | 1992-09-17 | 1994-12-02 | Lvmh Rech Gie | Composition cosmétique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux. |
US5863726A (en) | 1993-11-12 | 1999-01-26 | Geron Corporation | Telomerase activity assays |
JPH07238026A (ja) * | 1994-02-25 | 1995-09-12 | Pola Chem Ind Inc | 動脈硬化抑制剤及びこれを含む食品又は医薬 |
AT402890B (de) | 1994-03-16 | 1997-09-25 | Berbi Gmbh | Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln |
CZ3497A3 (en) * | 1994-07-07 | 1997-10-15 | Geron Corp | Rna component of mammal telomerase, oligonucleotide, recombinant expression plasmid containing the oligonucleotide, process for preparing eukaryotic host cell, process for preparing a recombinant telomerase enzyme |
US5583016A (en) | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
US6162459A (en) * | 1995-02-24 | 2000-12-19 | National Science Council | Acyclovir transdermal delivery system |
AUPN411195A0 (en) * | 1995-07-10 | 1995-08-03 | Cathay Herbal Laboratories Pty Ltd | Medicinal composition |
CN1079265C (zh) | 1995-08-01 | 2002-02-20 | 裴国增 | 灵芝口服液及其配制方法 |
US5785977A (en) * | 1996-02-07 | 1998-07-28 | Breithbarth; Richard | Non-metallic microparticle carrier materials |
US5916565A (en) * | 1996-03-08 | 1999-06-29 | In Clover, Inc. | Product and method for treating joint disorders in vertebrates |
TW452494B (en) * | 1996-03-12 | 2001-09-01 | Jang De Shan | Herbal composition for stimulating blood circulation |
US5900226A (en) * | 1997-04-09 | 1999-05-04 | Uop Llc | Drying agents for non-foamed polyurethanes |
JPH1036388A (ja) * | 1996-07-25 | 1998-02-10 | Kureha Chem Ind Co Ltd | ジンセノサイド類含有hsp47合成抑制剤 |
US6261836B1 (en) | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
AU734089B2 (en) | 1996-10-01 | 2001-06-07 | Geron Corporation | Human telomerase catalytic subunit |
US6093809A (en) | 1996-10-01 | 2000-07-25 | University Technology Corporation | Telomerase |
DE69838947T2 (de) * | 1997-01-28 | 2009-01-02 | Graeme A. Collingwood Close | Wasser/ethanol pflanzenextrakte aus centipeda cunninghamii |
US5786343A (en) * | 1997-03-05 | 1998-07-28 | Immudyne, Inc. | Phagocytosis activator compositions and their use |
ATE550010T1 (de) * | 1997-09-05 | 2012-04-15 | Procter & Gamble | Präparate zur reinigung und konditionierung von haut and haaren mit verbesserter ablagerung von konditionierenden bestandteilen |
KR100481563B1 (ko) * | 1997-09-12 | 2005-04-08 | 더 프록터 앤드 갬블 캄파니 | 피부 또는 모발용 세정 및 컨디셔닝 제품 |
IL137101A0 (en) | 1998-01-12 | 2001-06-14 | Cold Spring Harbor Lab | Extension of cellular lifespan, methods and reagents |
GB9815177D0 (en) * | 1998-07-13 | 1998-09-09 | King S College London | Treatment of skin disorders |
AU5338199A (en) | 1998-08-09 | 2000-02-28 | Geron Corporation | Methods and compositions for inhibiting or stimulating telomerase assembly |
WO2000031238A2 (en) | 1998-11-25 | 2000-06-02 | Genetica, Inc. | Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
JP2000204091A (ja) * | 1999-01-13 | 2000-07-25 | Nippon Suisan Kaisha Ltd | 新規ベンゾジオキソ―ル誘導体 |
JP2000229827A (ja) * | 1999-02-05 | 2000-08-22 | Kose Corp | 皮膚外用剤 |
JP2000229834A (ja) * | 1999-02-10 | 2000-08-22 | Kanebo Ltd | 化粧料 |
AUPQ127399A0 (en) | 1999-06-29 | 1999-07-22 | Guangzhou University Of Traditional Chinese Medicine | Compositions and methods for treating or preventing osteoporosis |
KR100858465B1 (ko) | 1999-09-10 | 2008-09-16 | 제론 코포레이션 | 올리고뉴클레오티드 엔3'→피5' 티오포스포라미데이트,이의 합성 및 용도 |
JP2001258505A (ja) * | 2000-03-24 | 2001-09-25 | Fancl Corp | 食品組成物 |
CA2307393A1 (en) * | 2000-05-01 | 2001-11-01 | The University Of British Columbia | Ginsenoside chemotherapy |
US6277396B1 (en) * | 2000-05-11 | 2001-08-21 | Maximum Human Performance, Inc. | Dietary supplement containing a thermogenic substance and an adrenal support substance |
WO2001092289A1 (fr) | 2000-05-31 | 2001-12-06 | Japan Science And Technology Corporation | Promoteurs de regeneration de tissu cutane contenant le ginsenoside rb1 |
CN1172677C (zh) | 2000-07-14 | 2004-10-27 | 复旦大学附属中山医院 | 黄芪甲苷在制备药物组合物中的应用 |
WO2002007732A2 (en) * | 2000-07-26 | 2002-01-31 | Cambridge University Technical Services Limited | Use of panaxatriol for stimulation angiogenesis |
GB0105613D0 (en) | 2001-03-07 | 2001-04-25 | Univ Cambridge Tech | Pharmaceutically effective compounds and their use |
US6696094B2 (en) * | 2000-10-18 | 2004-02-24 | Tzu-Sheng Wu | Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
CN1242807C (zh) * | 2000-11-08 | 2006-02-22 | 天津市延龄营养保健品有限公司 | 一种抗皮肤过敏的药物组合物及其制法和用途 |
CN1369276A (zh) * | 2001-02-12 | 2002-09-18 | 徐秀荣 | 有效减轻体重的组合物和方法 |
JP2002275086A (ja) * | 2001-03-15 | 2002-09-25 | Fancl Corp | 虚弱体質改善用組成物 |
AU2002342613A1 (en) | 2001-05-09 | 2002-11-25 | Geron Corporation | Treatment for wounds |
US20020182272A1 (en) * | 2001-05-30 | 2002-12-05 | Bruce Halstead | Methods of treatment of HIV-associated conditions |
JP2003089687A (ja) * | 2001-07-03 | 2003-03-28 | Tanabe Seiyaku Co Ltd | 新規ブタジエン誘導体、その製法およびその合成中間体 |
CN1522248A (zh) | 2001-07-03 | 2004-08-18 | 田边制药株式会社 | 新型丁二烯衍生物,制备它的方法及合成它的中间体 |
US20030108629A1 (en) * | 2001-07-17 | 2003-06-12 | Chou Wen Hsien | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
US6855344B2 (en) * | 2001-07-17 | 2005-02-15 | Integrated Chinese Medicine Holdings, Ltd. | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
CN1164608C (zh) * | 2001-08-31 | 2004-09-01 | 上海中医药大学 | 具有抗心肌纤维化作用的黄芪皂甙甲 |
CN1406585A (zh) * | 2001-09-07 | 2003-04-02 | 中国科学院上海药物研究所 | 一种治疗病毒性心肌炎的药物组合物 |
JP2003160497A (ja) * | 2001-11-22 | 2003-06-03 | Toshin Kagaku Kk | 皮膚外用剤 |
WO2003066814A2 (en) * | 2002-02-04 | 2003-08-14 | Ceremedix, Inc. | Peptide-dependent upregulation of telomerase expression |
CN1236803C (zh) | 2002-03-20 | 2006-01-18 | 郑国芃 | 一种治疗风湿症的中药 |
CN1189176C (zh) * | 2002-07-22 | 2005-02-16 | 江苏正大天晴药业股份有限公司 | 黄芪甲甙组合物及其制备方法 |
AU2003228378A1 (en) * | 2003-03-26 | 2004-11-23 | Westlake Partners | Herbal compositions and methods for effecting weight loss in humans |
CA2529852A1 (en) * | 2003-06-20 | 2004-12-29 | Viral Genomix, Inc. | Compositions for and methods for treating hiv |
TR201903587T4 (tr) * | 2003-06-23 | 2019-04-22 | Telomerase Activation Sciences Inc | Telomeraz aktivitesinin artırılması için bileşimler. |
WO2005000248A2 (en) | 2003-06-25 | 2005-01-06 | Geron Corporation | Compositions and methods for skin conditioning |
US20070122501A1 (en) * | 2003-06-27 | 2007-05-31 | Hong Kong University Of Science And Technology | Formulations containing astragalus extracts and uses thereof |
-
2004
- 2004-06-23 TR TR2019/03587T patent/TR201903587T4/tr unknown
- 2004-06-23 HU HUE12180710A patent/HUE043168T2/hu unknown
- 2004-06-23 AP AP2005003474A patent/AP2280A/xx active
- 2004-06-23 PL PL12180710T patent/PL2548880T3/pl unknown
- 2004-06-23 MX MXPA05013844A patent/MXPA05013844A/es active IP Right Grant
- 2004-06-23 JP JP2006517617A patent/JP5583882B2/ja active Active
- 2004-06-23 PT PT47770326T patent/PT1644009T/pt unknown
- 2004-06-23 KR KR1020057024720A patent/KR101312389B1/ko active IP Right Grant
- 2004-06-23 CN CN2004800172464A patent/CN1809364B/zh active Active
- 2004-06-23 PT PT12180710T patent/PT2548880T/pt unknown
- 2004-06-23 EA EA200600076A patent/EA009442B1/ru unknown
- 2004-06-23 LT LTEP12180710.1T patent/LT2548880T/lt unknown
- 2004-06-23 LT LTEP04777032.6T patent/LT1644009T/lt unknown
- 2004-06-23 TR TR2018/02543T patent/TR201802543T4/tr unknown
- 2004-06-23 CA CA2528483A patent/CA2528483C/en active Active
- 2004-06-23 AU AU2004251753A patent/AU2004251753C1/en not_active Ceased
- 2004-06-23 KR KR1020117017367A patent/KR20110089887A/ko active Application Filing
- 2004-06-23 SI SI200432463T patent/SI2548880T1/sl unknown
- 2004-06-23 EP EP04777032.6A patent/EP1644009B1/en active Active
- 2004-06-23 DK DK12180710.1T patent/DK2548880T3/en active
- 2004-06-23 NZ NZ544191A patent/NZ544191A/en unknown
- 2004-06-23 ES ES04777032.6T patent/ES2666864T3/es active Active
- 2004-06-23 ES ES12180710T patent/ES2716528T3/es active Active
- 2004-06-23 EP EP12180710.1A patent/EP2548880B1/en active Active
- 2004-06-23 US US10/562,374 patent/US7846904B2/en active Active
- 2004-06-23 PL PL04777032T patent/PL1644009T3/pl unknown
- 2004-06-23 WO PCT/US2004/020277 patent/WO2005000245A2/en active Application Filing
- 2004-06-23 KR KR1020137031630A patent/KR101465515B1/ko active IP Right Grant
- 2004-06-23 ZA ZA200509846A patent/ZA200509846B/en unknown
- 2004-06-23 SI SI200432425T patent/SI1644009T1/en unknown
- 2004-06-23 DK DK04777032.6T patent/DK1644009T3/en active
- 2004-06-23 HU HUE04777032A patent/HUE036559T2/hu unknown
- 2004-06-23 BR BRPI0411856-1A patent/BRPI0411856A/pt not_active Application Discontinuation
-
2008
- 2008-11-25 AU AU2008249200A patent/AU2008249200A1/en not_active Abandoned
-
2010
- 2010-03-05 US US12/718,812 patent/US8759304B2/en active Active
-
2011
- 2011-02-21 JP JP2011035191A patent/JP5841337B2/ja active Active
-
2013
- 2013-10-23 JP JP2013219989A patent/JP5913253B2/ja active Active
-
2014
- 2014-06-24 US US14/313,698 patent/US20150093455A1/en not_active Abandoned
-
2016
- 2016-01-04 JP JP2016000130A patent/JP2016041770A/ja not_active Withdrawn
-
2018
- 2018-02-23 HR HRP20180330TT patent/HRP20180330T1/hr unknown
- 2018-02-26 CY CY20181100225T patent/CY1119951T1/el unknown
-
2019
- 2019-02-18 HR HRP20190322TT patent/HRP20190322T1/hr unknown
- 2019-03-22 CY CY20191100342T patent/CY1121447T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE036559T2 (hu) | Készítmények telomeráz aktivitás fokozására és HIV fertõzés kezelésére | |
EP1753777A4 (en) | METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a | |
TWI347184B (en) | Methods of treating hiv infection | |
HK1088225A1 (en) | Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n | |
HUP0400609A3 (en) | Wet-skin treatment compositions | |
EP1651255A4 (en) | TOPICAL VETERINARY COMPOSITIONS AND METHODS OF TREATING AND PREVENTING INFECTIONS | |
SG118236A1 (en) | Compositions and methods for treating coronavirus infection and SARS | |
EP1461047A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ANIMALS | |
AU2003296963A8 (en) | Methods and compositions for treating and preventing ear infections | |
AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
GB0205531D0 (en) | Hair treatment compositions | |
IL187160A0 (en) | Compositions and methods for treating hiv infection with cupredoxin and cytochrome c | |
AU2002365168A8 (en) | Method and composition for treating and preventing hiv infection and aids | |
GB0300078D0 (en) | Composition for the treatment of HIV and AIDS | |
AU2003237088A8 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
AU2003258176A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
AU2003303948A8 (en) | Compositions and methods for preventing infection | |
AU2003275069A8 (en) | Compositions and methods for preventing infection | |
AU2002360523A8 (en) | Compounds to treat hiv infection and aids | |
AU2002327531A1 (en) | Therapeutic compositions and methods for treating viral infection | |
AU2003258177A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
AU2003299493A8 (en) | Compositions and methods for the treatment of hepatitis c virus infection | |
EP1693058A4 (en) | AGENT AND MEASURES FOR THE PREVENTION OF VIRAL INFECTION | |
IL187889A0 (en) | Compositions and methods for preventing or treating hiv infection | |
IL158901A0 (en) | Compositions for treating infected skin and mucous membrane |